JP2003201237A5 - - Google Patents

Download PDF

Info

Publication number
JP2003201237A5
JP2003201237A5 JP2002354833A JP2002354833A JP2003201237A5 JP 2003201237 A5 JP2003201237 A5 JP 2003201237A5 JP 2002354833 A JP2002354833 A JP 2002354833A JP 2002354833 A JP2002354833 A JP 2002354833A JP 2003201237 A5 JP2003201237 A5 JP 2003201237A5
Authority
JP
Japan
Prior art keywords
agent
preventing
bladder
agent according
dysuria
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002354833A
Other languages
Japanese (ja)
Other versions
JP2003201237A (en
JP3512786B2 (en
Filing date
Publication date
Application filed filed Critical
Priority to JP2002354833A priority Critical patent/JP3512786B2/en
Priority claimed from JP2002354833A external-priority patent/JP3512786B2/en
Publication of JP2003201237A publication Critical patent/JP2003201237A/en
Application granted granted Critical
Publication of JP3512786B2 publication Critical patent/JP3512786B2/en
Publication of JP2003201237A5 publication Critical patent/JP2003201237A5/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Claims (8)

８−［３−［１−［（３−フルオロフェニル）メチル］−４−ピペリジニル］−１−オキソプロピル］−１，２，５，６−テトラヒドロ−４Ｈ−ピロロ［３，２，１−ｉｊ］キノリン−４−オンまたはその塩を含有してなる膀胱排出力改善剤。8- [3- [1-[(3-Fluorophenyl) methyl] -4-piperidinyl] -1-oxopropyl] -1,2,5,6-tetrahydro-4H-pyrrolo [3,2,1-ij ] A bladder emptying agent comprising quinolin-4-one or a salt thereof. 排尿障害の予防・治療剤である請求項１記載の剤。The agent according to claim 1, which is an agent for preventing or treating dysuria. 排尿困難の予防・治療剤である請求項１記載の剤。The agent according to claim 1, which is a prophylactic / therapeutic agent for dysuria. 請求項１記載の化合物またはその塩とα−遮断薬とを組合わせることを特徴とする膀胱排出力改善剤。An agent for improving bladder drainage, comprising a combination of the compound according to claim 1 or a salt thereof and an α-blocker. 前立腺肥大症に伴う排尿障害の予防・治療剤である請求項１記載の剤。The agent according to claim 1, which is an agent for preventing or treating dysuria associated with benign prostatic hyperplasia. 神経因性膀胱に起因する排尿障害の予防・治療剤である請求項１記載の剤。The agent according to claim 1, which is an agent for preventing or treating dysuria caused by neurogenic bladder. 膀胱筋緊張低下に起因する排尿障害の予防・治療剤である請求項１記載の剤。The agent according to claim 1, which is an agent for preventing or treating dysuria caused by hypotonia of the bladder muscle. 頻尿・尿失禁の予防・治療剤である請求項１記載の剤。The agent according to claim 1, which is a prophylactic / therapeutic agent for pollakiuria / urinary incontinence.
JP2002354833A 1998-09-30 2002-12-06 Bladder drainage improver Expired - Fee Related JP3512786B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2002354833A JP3512786B2 (en) 1998-09-30 2002-12-06 Bladder drainage improver

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP27667798 1998-09-30
JP10-276677 1998-09-30
JP2002354833A JP3512786B2 (en) 1998-09-30 2002-12-06 Bladder drainage improver

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP11275614A Division JP2000169373A (en) 1998-09-30 1999-09-29 Bladder-discharging power-improving agent

Publications (3)

Publication Number Publication Date
JP2003201237A JP2003201237A (en) 2003-07-18
JP3512786B2 JP3512786B2 (en) 2004-03-31
JP2003201237A5 true JP2003201237A5 (en) 2004-07-08

Family

ID=27666100

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002354833A Expired - Fee Related JP3512786B2 (en) 1998-09-30 2002-12-06 Bladder drainage improver

Country Status (1)

Country Link
JP (1) JP3512786B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110262566A1 (en) * 2008-11-07 2011-10-27 Dainippon Sumitomo Pharma Co., Ltd. Novel useful therapeutic agent for lower urinary tract symptom

Similar Documents

Publication Publication Date Title
JP2009524676A5 (en)
WO2008051599A3 (en) Combination therapies for treating alzheimer's disease using i. a. dimebon and dolepezil
NO20080187L (en) Disclosed are
RS53904A (en) 1-alkyl-1-azoniabicyclo/2.2.2./octane carbamate derivatives and their use as muscarinic receptor antagonists
WO2004101528A3 (en) Isoquinoline derivatives and their use as gfat inhibitors
NO20070247L (en) Amino-5,5-diphenylimidazolone derivatives for inhibition of beta-secretase
JP2008517913A5 (en)
WO2006138266A3 (en) The preparation and use of compounds as aspartyl protease inhibitors
WO2005107747A3 (en) Diindolymethane formulations for the treatment of leiomyomas
WO2002000622A3 (en) Aminoalcohol derivatives
WO2000071493A3 (en) INHIBITORS OF FACTOR Xa
ATE421501T1 (en) 2,7-SUBSTITUTED 5-AMINO-4-HYDROXY-8-(1H-INDOL-5-YL)-OCTANAMIDE DERIVATIVES AS RENIN INHIBITORS FOR THE TREATMENT OF HYPERTENSION
WO1999065571A3 (en) Use of optically pure (+)-norcisapride for treating apnea, bulimia and other disorders
CA2438596A1 (en) Tetrahydro-pyrazino (1,2-a) indoles for the treatment of central nervous disorders
NO20034864L (en) Preparation for the treatment of drug-induced constipation with 15-keto-prostaglandins
CA2411008A1 (en) Derivatives of 2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione
JP2010155827A5 (en)
JP2005533052A5 (en)
WO2006050861A3 (en) Statine derivatives for the treatment of alzheimer's disease
SG153822A1 (en) Novel oxabispidine compounds and their use in the treatment of cardiac arrhythmias
JP2003201237A5 (en)
NO20023038L (en) New azabicyclooctane derivatives for use in the treatment of cardiac arrhythmias
WO2007134132A3 (en) Compositions and methods for the diagnosis and treatment of bladder and urinary tract tumors
WO2004009030A3 (en) Angiogenesis inhibition by cephalotaxine alkaloids, derivatives, compositions and uses thereof
NZ543615A (en) (1S,5s)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0] heptane is an effective analgesic agent